Wang, Y., Liu, H., Wang, Q., Qiao, N., Wang, J., Tan, B., Cheng, B., Chu, Y., Zhao, C., Chen, X., Cheng, Y. (2025). Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 plus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): Survival results of a phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.411